Branded

Infugem is the first and only chemotherapy product in a premixed, ready-to-infuse formulation.

Zelnorm was originally approved by the FDA in 2002 for the treatment of IBS-C in women

Bausch + Lomb's Lotemax SM is designed with SubMicron technology and is indicated to treat postoperative inflammation and pain following ocular surgery.

Fera also was granted orphan drug exclusivity, providing seven years of marketing exclusivity for the product.

Jatenzo's oral route of administration provides a new treatment option for men with certain hypogonadal conditions.

Sunosi provides a treatment for obstructive sleep apnea and narcolepsy patients with excessive daytime sleepiness.

Tecentriq is the first cancer immunotherapy approved for the initial treatment of extensive-stage small-cell lung cancer

This is the first Food and Drug Administration approval of a pediatric indication for complicated intra-abdominal infections and complicated urinary tract infections in more than a decade, Allergan said.